Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Pharmacokinetics in Pediatric Patients: Drug Excretion01:26

Pharmacokinetics in Pediatric Patients: Drug Excretion

391
In pediatric medicine, understanding the renal function and drug elimination nuances is crucial for administering safe and effective treatments. Newborns, in particular, display markedly slower renal functions than adults, profoundly affecting how drugs are cleared from their bodies. This slower drug clearance requires clinicians to extend the dosing intervals for many medications to prevent drug accumulation and toxicity while ensuring therapeutic efficacy.One key area where these adjustments...
391
Pharmacokinetics in Pediatric Patients: Overview and Drug Absorption01:23

Pharmacokinetics in Pediatric Patients: Overview and Drug Absorption

886
Understanding the physiological differences in the pediatric population is crucial for effective pharmacotherapy. Neonates, infants, and children exhibit significant variations in gastric pH, gastric emptying time, intestinal transit time, and biliary function. These variations profoundly affect oral drug absorption, necessitating a nuanced approach to pediatric dosing.Neonates present with a unique physiological profile, having a gastric pH greater than 4 and faster and more irregular gastric...
886
Pharmacokinetics in Pediatric Patients: Drug Metabolism01:24

Pharmacokinetics in Pediatric Patients: Drug Metabolism

371
In pediatric care, understanding the nuances of hepatic drug metabolism is crucial, as it significantly differs from that of adults. This divergence is primarily due to the developmental stage of drug-metabolizing enzymes, which affects how medications are processed in the body. In neonates, for instance, the activity of Phase I enzymes—critical for the initial breakdown of drugs—is markedly reduced, functioning at just 20–40% of the levels seen in adults. This reduction poses...
371
Immunodeficiency Diseases01:25

Immunodeficiency Diseases

3.7K
Immunodeficiency disorders are conditions in which the immune system's ability to fight infectious disease and cancer is compromised or entirely absent. The immune system comprises a complex network of cells, tissues, and organs that work together to protect the body from potentially harmful invaders. When this system is deficient or not functioning properly, it leaves the body susceptible to infections, diseases, or other complications.
There are three main causes of immunodeficiency...
3.7K
Pharmacokinetics in Pediatric Patients: Drug Distribution01:17

Pharmacokinetics in Pediatric Patients: Drug Distribution

513
Drug distribution in the pediatric population exhibits unique challenges and considerations due to the physiological differences between children, particularly neonates and infants, and adults. A crucial aspect of pediatric pharmacology is understanding how these differences impact the pharmacokinetics of various drugs, necessitating age-specific dosing strategies to ensure efficacy and safety.Neonates and infants have a higher total body water content, ~75%–90% of their body weight,...
513
Cystic Fibrosis: Management01:24

Cystic Fibrosis: Management

656
Cystic fibrosis (CF) is an autosomal recessive disorder that predominantly affects individuals of Northern European descent, occurring at a rate of 1 in 3500. It is caused by a genetic mutation in a gene on chromosome 7, most commonly the ΔF508 mutation, that codes for the cystic fibrosis transmembrane conductance regulator (CFTR) protein. This results in thicker mucus secretions and obstruction pathologies in multiple organs, including the lungs and sinuses.
Sinus disease and chronic...
656

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Assessment of dried blood spot and umbilical cord blood samples for the quantification of maternally transferred IgG against the group B streptococcal alpha-like surface proteins in neonates at Kolding Hospital, Denmark: a proof-of-concept, cross-sectional study.

The Lancet. Microbe·2026
Same author

Catch-up and life-course vaccination policies for adult and adolescent migrants in low-and-middle income countries: A policy analysis.

Vaccine·2026
Same author

SARS-CoV-2 seroprevalence among pregnant women during the first three waves of the COVID-19 pandemic in southern Mozambique.

BMC pregnancy and childbirth·2026
Same author

Establishing an International Psychoanalytic Nurses Alliance [IPNA].

Journal of psychiatric and mental health nursing·2026
Same author

A fungal pathobiont promotes Streptococcus vaginal persistence and pathogenesis through physical and metabolic interactions.

Cell host & microbe·2026
Same author

Maternal Group B <i>Streptococcus</i> Vaccination: A Three-Country European Consortium to Improve Surveillance and Data Readiness.

Clinical epidemiology·2026

Related Experiment Video

Updated: Apr 19, 2026

New Tools to Expand Regulatory T Cells from HIV-1-infected Individuals
09:27

New Tools to Expand Regulatory T Cells from HIV-1-infected Individuals

Published on: May 30, 2013

11.7K

Virtual support for paediatric HIV treatment decision making.

Kirsty Le Doare1, N E Mackie2, S Kaye2

  • 1St. Mary's Hospital, Imperial College NHS Trust, London, UK Department of Paediatrics, Imperial College London, London, UK.

Archives of Disease in Childhood
|January 1, 2015
PubMed
Summary

The multidisciplinary paediatric virtual clinic (PVC) effectively managed complex paediatric HIV cases, improving treatment outcomes and simplifying regimens. This model shows promise for other rare childhood diseases.

Keywords:
HIVInformation TechnologyPharmacology

More Related Videos

An Affordable HIV-1 Drug Resistance Monitoring Method for Resource Limited Settings
19:57

An Affordable HIV-1 Drug Resistance Monitoring Method for Resource Limited Settings

Published on: March 30, 2014

19.5K
Comprehensive & Cost Effective Laboratory Monitoring of HIV/AIDS: an African Role Model
23:56

Comprehensive & Cost Effective Laboratory Monitoring of HIV/AIDS: an African Role Model

Published on: October 31, 2010

17.4K

Related Experiment Videos

Last Updated: Apr 19, 2026

New Tools to Expand Regulatory T Cells from HIV-1-infected Individuals
09:27

New Tools to Expand Regulatory T Cells from HIV-1-infected Individuals

Published on: May 30, 2013

11.7K
An Affordable HIV-1 Drug Resistance Monitoring Method for Resource Limited Settings
19:57

An Affordable HIV-1 Drug Resistance Monitoring Method for Resource Limited Settings

Published on: March 30, 2014

19.5K
Comprehensive & Cost Effective Laboratory Monitoring of HIV/AIDS: an African Role Model
23:56

Comprehensive & Cost Effective Laboratory Monitoring of HIV/AIDS: an African Role Model

Published on: October 31, 2010

17.4K

Area of Science:

  • Paediatric Infectious Diseases
  • Clinical Management Models
  • HIV/AIDS Research

Background:

  • Paediatric HIV infection requires complex management strategies.
  • Tertiary care networks facilitate specialized care for children.
  • Multidisciplinary approaches enhance treatment decision-making.

Purpose of the Study:

  • To review clinical outcomes of a paediatric virtual clinic (PVC) for complex paediatric HIV case management.
  • To evaluate the PVC as a model of care within a tertiary network.
  • To assess the impact of multidisciplinary recommendations on patient outcomes.

Main Methods:

  • Retrospective review of paediatric and adolescent referrals (0-21 years) to a PVC.
  • Data collected from October 2009 to November 2013 at St. Mary's Hospital, Imperial College Healthcare NHS Trust.
  • Analysis of clinical outcomes following PVC recommendations.

Main Results:

  • 234 referrals for 182 children; 80% of PVC advice was implemented.
  • Successful viral suppression achieved in 48% after first referral for virological failure.
  • 95% of children on simplified regimens maintained viral suppression; 73% normalized liver function.
  • Adherence support resolved viraemia in nine children; 12% received additional psychosocial support.

Conclusions:

  • Multidisciplinary virtual input, combining adult and paediatric expertise, aids complex paediatric HIV treatment decisions.
  • The Virtual Clinic model effectively manages paediatric HIV and can be adapted for other rare childhood diseases.
  • Integration of specialized knowledge and support services optimizes care delivery.